Viatris-collaborated trial registered comparing Yupelri/Perforomist combo to standard COPD therapyJul 23Trial updateformoterolrevefenacin
ARS Pharmaceuticals posts Phase 2 results for intranasal epinephrine ARS-1 in asthmaJul 14Trial updateARS Pharmaceuticals, Inc.
Sign inSign in